Lexington Receives Approval to Commence Clinical Study
24 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Completes IRB Submission in Preparation for Clinical Study
18 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 18, 2018 (GLOBE NEWSWIRE) --
Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device...
Lexington Biosciences Announces Exercise of Warrants
11 janv. 2018 09h00 HE
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...